Ubs Asset Management Americas Inc X Biotech Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 248,270 shares of XBIT stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248,270Holding current value
$1.75 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XBIT
# of Institutions
47Shares Held
4.67MCall Options Held
5.8KPut Options Held
4.6K-
Black Rock Inc. New York, NY1.13MShares$8.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$7.32 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA430KShares$3.04 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny362KShares$2.55 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.75 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $215M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...